These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Bone health in cystic fibrosis: use of oral bisphosphonates. Le Henaff C; Velard F; Jacquot J Lancet Respir Med; 2013 Jul; 1(5):349-50. PubMed ID: 24429188 [No Abstract] [Full Text] [Related]
48. Low creatinine clearance, glucocorticoid treatment, rheumatoid arthritis--different etiologies for low D-hormone syndrome and its associated increased risk for falls. Dukas LC; Schacht E J Rheumatol Suppl; 2005 Sep; 76():44-6. PubMed ID: 16142851 [TBL] [Abstract][Full Text] [Related]
49. Alendronate may enhance implant osseointegration, study finds. J Am Dent Assoc; 2008 Jun; 139(6):679-80. PubMed ID: 18519989 [No Abstract] [Full Text] [Related]
50. [Alendronate and mouth ulcers: careful interrogation of the patient to start with]. Schmutz JL; Barbaud A; Trechot P Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):930. PubMed ID: 16327732 [No Abstract] [Full Text] [Related]
51. Case of alfacalcidol-induced hypercalcemia presenting as bipolar disorder. Tamiya H; Okamura T; Iwashiro N; Ishiki K; Yamasue H; Kasai K Psychiatry Clin Neurosci; 2011 Aug; 65(5):536-7. PubMed ID: 21851468 [No Abstract] [Full Text] [Related]
52. The Large Pharmaceutical Company Perspective. Rosenblatt M N Engl J Med; 2017 Jan; 376(1):52-60. PubMed ID: 28052221 [No Abstract] [Full Text] [Related]
53. Potential of alfacalcidol for reducing increased risk of falls and fractures. Ringe JD; Schacht E Rheumatol Int; 2009 Aug; 29(10):1177-85. PubMed ID: 19159932 [TBL] [Abstract][Full Text] [Related]
54. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. Schacht E; Richy F; Reginster JY J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518 [TBL] [Abstract][Full Text] [Related]
56. Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosis. Ringe JD; Schacht E; Dukas L; Mazor Z Arzneimittelforschung; 2011; 61(2):104-11. PubMed ID: 21428245 [TBL] [Abstract][Full Text] [Related]
57. Risk reduction of falls and fractures, reduction of back pain and safety in elderly high risk patients receiving combined therapy with alfacalcidol and alendronate: a prospective study. Schacht E; Ringe JD Arzneimittelforschung; 2011; 61(1):40-54. PubMed ID: 21355445 [TBL] [Abstract][Full Text] [Related]